World Tuberculosis Day

US FDA Grants Priority Review to Jemperli for dMMR/MSI-H Locally Advanced Rectal Cancer; Amylyx’s Avexitide Achieves Positive Topline Results in Phase 3 LUCIDITY Study; Ultragenyx Marks Major Milestone as FDA Approves GENGLYCOS for GSDIa; Pasatru Receives FDA Approval for Fibrodysplasia Ossificans Progressiva; Merck and Moderna’s Intismeran Autogene Plus KEYTRUDA Delivers Positive Phase 3 Results in Resected Melanoma

Each Year 24^th March is recognized as World Tuberculosis Day. Tuberculosis resulted in 1.6 million deaths in 2017 worldwide. This year let us make an aim to end TB. Work for Zero deaths from TB.  The cure for TB exists. Spread the word, not the disease.